BACKGROUND: Age-related cerebrovascular and neuroinflammatory processes have been independently identified as key mechanisms of Alzheimer's disease (AD), although their interactive effects have yet to be fully examined. OBJECTIVE: The current study examined 1) the influence of pulse pressure (PP) and inflammatory markers on AD protein levels and 2) links between protein biomarkers and cognitive function in older adults with and without mild cognitive impairment (MCI). METHODS: This study included 218 ADNI (81 cognitively normal [CN], 137 MCI) participants who underwent lumbar punctures, apolipoprotein E (APOE) genotyping, and cognitive testing. Cerebrospinal (CSF) levels of eight pro-inflammatory markers were used to create an inflammation composite, and amyloid-beta 1-42 (Aβ42), phosphorylated tau (p-tau), and total tau (t-tau) were quantified. RESULTS: Multiple regression analyses controlling for age, education, and APOE ɛ4 genotype revealed significant PP x inflammation interactions for t-tau (B = 0.88, p = 0.01) and p-tau (B = 0.84, p = 0.02); higher inflammation was associated with higher levels of tau within the MCI group. However, within the CN group, analyses revealed a significant PP x inflammation interaction for Aβ42 (B = -1.01, p = 0.02); greater inflammation was associated with higher levels of Aβ42 (indicative of lower cerebral amyloid burden) in those with lower PP. Finally, higher levels of tau were associated with poorer memory performance within the MCI group only (p s < 0.05). CONCLUSION: PP and inflammation exert differential effects on AD CSF proteins and provide evidence that vascular risk is associated with greater AD pathology across our sample of CN and MCI older adults.
BACKGROUND: Age-related cerebrovascular and neuroinflammatory processes have been independently identified as key mechanisms of Alzheimer's disease (AD), although their interactive effects have yet to be fully examined. OBJECTIVE: The current study examined 1) the influence of pulse pressure (PP) and inflammatory markers on AD protein levels and 2) links between protein biomarkers and cognitive function in older adults with and without mild cognitive impairment (MCI). METHODS: This study included 218 ADNI (81 cognitively normal [CN], 137 MCI) participants who underwent lumbar punctures, apolipoprotein E (APOE) genotyping, and cognitive testing. Cerebrospinal (CSF) levels of eight pro-inflammatory markers were used to create an inflammation composite, and amyloid-beta 1-42 (Aβ42), phosphorylated tau (p-tau), and total tau (t-tau) were quantified. RESULTS: Multiple regression analyses controlling for age, education, and APOE ɛ4 genotype revealed significant PP x inflammation interactions for t-tau (B = 0.88, p = 0.01) and p-tau (B = 0.84, p = 0.02); higher inflammation was associated with higher levels of tau within the MCI group. However, within the CN group, analyses revealed a significant PP x inflammation interaction for Aβ42 (B = -1.01, p = 0.02); greater inflammation was associated with higher levels of Aβ42 (indicative of lower cerebral amyloid burden) in those with lower PP. Finally, higher levels of tau were associated with poorer memory performance within the MCI group only (p s < 0.05). CONCLUSION: PP and inflammation exert differential effects on AD CSF proteins and provide evidence that vascular risk is associated with greater AD pathology across our sample of CN and MCI older adults.
Authors: Hanna Cho; Jae Yong Choi; Mi Song Hwang; You Jin Kim; Hye Mi Lee; Hye Sun Lee; Jae Hoon Lee; Young Hoon Ryu; Myung Sik Lee; Chul Hyoung Lyoo Journal: Ann Neurol Date: 2016-07-08 Impact factor: 10.422
Authors: Paramita Chakrabarty; Andrew Li; Carolina Ceballos-Diaz; James A Eddy; Cory C Funk; Brenda Moore; Nadia DiNunno; Awilda M Rosario; Pedro E Cruz; Christophe Verbeeck; Amanda Sacino; Sarah Nix; Christopher Janus; Nathan D Price; Pritam Das; Todd E Golde Journal: Neuron Date: 2015-01-22 Impact factor: 17.173
Authors: Peter Parbo; Rola Ismail; Michael Sommerauer; Morten G Stokholm; Allan K Hansen; Kim V Hansen; Ali Amidi; Jeppe L Schaldemose; Hanne Gottrup; Hans Brændgaard; Simon F Eskildsen; Per Borghammer; Rainer Hinz; Joel Aanerud; David J Brooks Journal: Neurobiol Dis Date: 2018-06-11 Impact factor: 5.996
Authors: Joel S Eppig; Emily C Edmonds; Laura Campbell; Mark Sanderson-Cimino; Lisa Delano-Wood; Mark W Bondi Journal: J Int Neuropsychol Soc Date: 2017-06-05 Impact factor: 2.892
Authors: Rola Ismail; Peter Parbo; Lasse Stensvig Madsen; Allan K Hansen; Kim V Hansen; Jeppe L Schaldemose; Pernille L Kjeldsen; Morten G Stokholm; Hanne Gottrup; Simon F Eskildsen; David J Brooks Journal: J Neuroinflammation Date: 2020-05-06 Impact factor: 8.322
Authors: Rachel A Bernier; Sarah J Banks; Matthew S Panizzon; Murray J Andrews; Emily G Jacobs; Douglas R Galasko; Alyx L Shepherd; Katerina Akassoglou; Erin E Sundermann Journal: Alzheimers Dement (Amst) Date: 2022-04-01